This broadens the canonical view of IFN-I as a Th1-polarizing cytokine, implicating it in direct effector licensing of CD4+ T cells, particularly relevant in DM lesions, where IFN-I and GZMB+ CD4+ T cells were most abundant. This evidence concerns the gene CD4 and dermatomyositis.